Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico

Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico

Type 2 diabetes is an important social and health care system variable due to its large diffusion, frequency of clinical complications and its health care costs. The studied population is relative to 4 italian centers distributed all over the country (Brescia, Roma, Rossano Calabro and Avola). This...

Full description

Bibliographic Details
Main Authors: Gianluca Falcitelli, Giuseppe Armentano, Corrado Pugliesi, Patrizio Tatti, Antonio Cimino
Format: Article
Language:English
Published: SEEd Medical Publishers 2006-09-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
type 2 diabetes
oral anti-diabetics
insuline
epidemiology
hba1c
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/682
id doaj-f9082af236e840a0817eb0b9eba01d75
record_format Article
spelling doaj-f9082af236e840a0817eb0b9eba01d752020-11-25T01:42:35ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2006-09-017212513410.7175/fe.v7i2.682633Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentricoGianluca Falcitelli0Giuseppe Armentano1Corrado Pugliesi2Patrizio Tatti3Antonio Cimino4Consulente statistico, via G. Barzellotti 8, Roma 
Specialista in Diabetologia e Malattie del Ricambio, Direttore centro Diabetologico DEA di Rossano (CS) 
Ambulatorio di Diabetologia, Avola 
U.O.C.Aziendale, AUSL Roma H, Roma 
Dirigente Medico, UO di Diabetologia, Spedali Civili di Brescia

Type 2 diabetes is an important social and health care system variable due to its large diffusion, frequency of clinical complications and its health care costs. The studied population is relative to 4 italian centers distributed all over the country (Brescia, Roma, Rossano Calabro and Avola). This work has the aim to describe the Italian type 2 population according to treatment choice ruled by diabetes stage, glycemia control and HbA1c concentration. The analysis present a description of the therapeutic changes during the year of observation too, giving a complete picture of patients distribution and their treatment path through diabetes evolution in Italy.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/682type 2 diabetesoral anti-diabeticsinsulineepidemiologyhba1c
collection DOAJ
language English
format Article
sources DOAJ
author Gianluca Falcitelli
Giuseppe Armentano
Corrado Pugliesi
Patrizio Tatti
Antonio Cimino
spellingShingle Gianluca Falcitelli
Giuseppe Armentano
Corrado Pugliesi
Patrizio Tatti
Antonio Cimino
Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
Farmeconomia: Health Economics and Therapeutic Pathways
type 2 diabetes
oral anti-diabetics
insuline
epidemiology
hba1c
author_facet Gianluca Falcitelli
Giuseppe Armentano
Corrado Pugliesi
Patrizio Tatti
Antonio Cimino
author_sort Gianluca Falcitelli
title Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
title_short Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
title_full Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
title_fullStr Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
title_full_unstemmed Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
title_sort resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico
publisher SEEd Medical Publishers
series Farmeconomia: Health Economics and Therapeutic Pathways
issn 2240-256X
publishDate 2006-09-01
description Type 2 diabetes is an important social and health care system variable due to its large diffusion, frequency of clinical complications and its health care costs. The studied population is relative to 4 italian centers distributed all over the country (Brescia, Roma, Rossano Calabro and Avola). This work has the aim to describe the Italian type 2 population according to treatment choice ruled by diabetes stage, glycemia control and HbA1c concentration. The analysis present a description of the therapeutic changes during the year of observation too, giving a complete picture of patients distribution and their treatment path through diabetes evolution in Italy.
topic type 2 diabetes
oral anti-diabetics
insuline
epidemiology
hba1c
url https://journals.seedmedicalpublishers.com/index.php/FE/article/view/682
work_keys_str_mv AT gianlucafalcitelli resistenzaallusodegliipoglicemizzantioralineltrattamentodeldiabetetipo2unostudiomulticentrico
AT giuseppearmentano resistenzaallusodegliipoglicemizzantioralineltrattamentodeldiabetetipo2unostudiomulticentrico
AT corradopugliesi resistenzaallusodegliipoglicemizzantioralineltrattamentodeldiabetetipo2unostudiomulticentrico
AT patriziotatti resistenzaallusodegliipoglicemizzantioralineltrattamentodeldiabetetipo2unostudiomulticentrico
AT antoniocimino resistenzaallusodegliipoglicemizzantioralineltrattamentodeldiabetetipo2unostudiomulticentrico
_version_ 1725035359851511808

Similar Items